ICPT
Intercept Pharmaceuticals, Inc.
ICPT
ICPT
Delisted
ICPT was delisted on the 7th of November, 2023.
125 hedge funds and large institutions have $387M invested in Intercept Pharmaceuticals, Inc. in 2023 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 46 increasing their positions, 41 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
70% less call options, than puts
Call options by funds: $9.77M | Put options by funds: $32.2M
Holders
125
Holding in Top 10
2
Calls
$9.77M
Puts
$32.2M
Top Buyers
| 1 | +$23M | |
| 2 | +$14.8M | |
| 3 | +$14.3M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$13.7M |
| 5 |
State Street
Boston,
Massachusetts
|
+$12.5M |
Top Sellers
| 1 | -$7.3M | |
| 2 | -$6.73M | |
| 3 | -$5.89M | |
| 4 |
Goldman Sachs
New York
|
-$5.15M |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
-$4.23M |